Jamie Grooms

Mr. Grooms co-founded Regeneration Technologies (Nasdaq: RTIX), a publicly-traded company that processes human tissue for allogenic grafts used in orthopedic, oral maxillofacial, urinary, and cardiovascular surgeries. He co-invented the primary value-added technologies that formed the basis of RTIX’s product line. Mr. Grooms also co-founded AxoGen Corporation, and from 2002 to May 2010 he served as Chief Executive Officer. He had been AxoGen Corporation’s Chairman of the Board of Directors since 2002 and then served as AxoGen, Inc.’s Chairman of Board of Directors since 2011. In addition to his executive management experience, he has extensive experience in many areas of med-tech business operations, including R&D, laboratory and manufacturing operations. He has developed state-of-the-art medical processing and manufacturing systems, robotics, and other technological innovations, and has held various leadership positions with LifeNet, Osteotech (Nasdaq:OSTE), and CryoLife (Nasdaq:CRY). Mr. Grooms holds a degree in biology from Old Dominion University.